Because C3f, as a fragment of complement C3, exists throughout the blood circulation and within tumor tissues, it remains unclear whether other protease(s) among possibly hundreds in biofluids, in addition to MMP-9, could also specifically cleave C3f4. This evidence concerns the gene C3 and neoplasm.